CCM® Therapy — My Approach to Identifying Patients

CCM® Therapy

M. Emig, S. Toth-Manikowski, D. McCaskill

HRS 2024: Cardiac Contractility Modulation - Don’t Wait!

CCM® Therapy

R. Kahwash

Heart Failure with Preserved Ejection Fraction: Current Perspectives…

American College of Cardiology

S. Shah

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

CVRx | Barostim

J. Thomas Heywood

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

CVRx | Barostim

W. Abraham, F. Arribas, M. Zile

Challenges and Opportunities with Contemporary GDMT

CVRx | Barostim

D. Yaranov

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

CVRx | Barostim

W. Abraham

Baroreflex Activation Therapy Overview of Clinical Data

CVRx | Barostim

L. Tsao

Extended Anticoagulation for VTE

Jeffrey Weitz

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

American Heart & Vascular Institute

M. Kittleson

ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…

American Heart & Vascular Institute

B. Reddy

Diabetes and Heart Failure: The New Frontier

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

E. Braunwald

The CCM Solution: How Does it Work and What Does it Do?

CCM® Therapy

N. Varma

The ISCHEMIA Trial: Are There Differences in Primary and Secondary O…

Mount Sinai

G. Stone

Barostim Clinical Evidence

CVRx | Barostim

L. Grazette

Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evalua…

Terumo Interventional Systems

J. Spertus

Right Ventricular Failure: Diagnosis and Management

Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

A. Srivastava

The Heart Failure Problem: When Guideline-Directed Medical Therapy i…

CCM® Therapy

C. Linde

'Heart Failure: Future perspectives

Arun Kochar

A. Kochar

Baroreflex Activation Therapy: A Novel Approach for HFrEF Patients H…

CVRx | Barostim

M. Fudim, R. Cole, L. Grazette